Invivyd (IVVD) EBIAT (2021 - 2025)

Invivyd (IVVD) has 5 years of EBIAT data on file, last reported at -$11.1 million in Q4 2025.

• For the quarter ending Q4 2025, EBIAT rose 39.92% year-over-year to -$11.1 million; the trailing twelve-month figure through Dec 2025 stood at -$52.5 million (up 69.1% YoY), and the FY2025 full-year result was -$52.5 million, up 69.1% from the prior year.
• EBIAT for Q4 2025 stood at -$11.1 million, down from -$10.5 million in the prior quarter.
• Across five years, EBIAT topped out at -$10.5 million in Q3 2025 and bottomed at -$100.7 million in Q1 2022.
• The 5-year median for EBIAT is -$44.6 million (2021), against an average of -$44.5 million.
• The widest annual swing landed in 2022, when EBIAT tumbled 160.12%; it then surged 82.76% in 2025.
• A 5-year view of EBIAT shows it stood at -$83.0 million in 2021, then surged by 46.32% to -$44.6 million in 2022, then slumped by 65.24% to -$73.7 million in 2023, then soared by 74.96% to -$18.4 million in 2024, then surged by 39.92% to -$11.1 million in 2025.
• The last three EBIAT figures came in at -$11.1 million (Q4 2025), -$10.5 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.

Peer Comparison